Table 2 Type of included study, number of patients analyzed, target population and peak age of incidence.
From: Trends and characteristics of oral and maxillofacial injuries in Nigeria: a review of the literature
Author (Ref.-No.) | Type of study | n of patients | Target population | Bone mostly affected (%) | Peak age of incidence, years (%) |
|---|---|---|---|---|---|
Ajagbe et al (21) | retrospective | 203 | total | mandible (60.5) | 21–30 (32) |
Nwoku et al (36) | retrospective | 84 | total | mandible (90) | ## |
Ajagbe et al (34) | retrospective | 324 | total | mandible (60) | 21–30 |
Adekeye (47) | prospective | 1447 | total | mandible (62.5) | 21–30 (56) |
Adekeye (48) | retrospective | 337 | total | # | 21–40 (80) |
Adekeye (49) | retrospective | 85 | Children | mandible | >10 |
Nyako (23) | retrospective | 341 | total | mandible (73) | 21–30 (46) |
Odusanya (41) | retrospective | 231 | total | mandible (67) | 21–30 |
Abiose (22) | retrospective | 104 | total | mandible (75) | 21–30 (43) |
Akinwande (37) | prospective | 208 | total | mandible | 21–30 (51) |
Abiose (32) | retrospective | 59 | total | # | 21–30 |
Arotiba (38) | prospective | 128 | total | mandible (62) | 20–29 (>40) |
Arotiba (39) | prospective | 202 | total | mandible (64) | 20–29 (40) |
Oji (15) | retrospective | 900 | total | mandible (42) | 21–30 (36) |
Ogunbodede (52) | case report | 1 | # | # | # |
Denloye et al (33) | retrospective | 106 | Children | mandible | 0–8 (62) |
Ugboko et al (1) | retrospective | 442 | total | mandible (64) | 21–30 (39) |
Akinwande et al (40) | prospective | 35 | total | mandible | 20–34 (66) |
Oji (55) | retrospective | 40 | Children | mandible (89) | 9–11 (40) |
Ugboko et al (46) | retrospective | 52 | Children | mandible (62) | 12–14 (50) |
Oji (16) | retrospective | 900 | total | mandible (53) | 21–30 (36) |
Olasoji (53) | retrospective | 105 | total | mandible (43) | 20–29 (42) |
Ugboko et al (42) | retrospective | 22 | total | Zygoma (27) | 21–40 |
Fasola et al (28) | retrospective | 77 | total | mandible (54.4) | 21–30 (52) |
Fasola et al (30) | retrospective | 831 | total | # | 21–30 (33) |
Fasola et al (19) | prospective | 103 | total | # | 21–30 (47) |
Fasola et al (25) | retrospective | 93 | children | mandible (86) | 11–16 (54) |
Fasola et al (26) | retrospective | 72 | children | # | 12–16 (57) |
Olasoji et al (4) | prospective | 306 | total | mandible (66) | 21–30 (41) |
Olasoji et al (54) | retrospective | 102 | Children | mandible (73) | 12–15 (54) |
Ugboko et al (51) | retrospective | 34 | total | mandible (56) | 11–30 (74) |
Oginni et al (43) | retrospective | 8 | children | # | ## |
Oginni et al (44) | retrospective | 174 | children | # | ## |
Fasola et al (29) | aretrospective | 531 | total | # | 21–30 (39) |
Fasola et al (31) | prospective | 76 | total | # | 21–30 (51) |
Fasola et al (18) | bpro/retrospective | 824 | total | mandible (75) | 21–30 (36) |
Fasola et al (24) | prospective | 159 | total | mandible | 21–30 (36) |
Fasola et al (27) | retrospective | 53 | adults | mandible (96) | 60–70 (77) |
Saheeb et al (56) | retrospective | 250 | total | mandible (65) | 20–30 (32) |
Adebayo et al (50) | retrospective | 443 | total | mandible (64) | 20–39 (65) |
Bankole et al (35) | retrospective | 64 | children | # | 0–5 |
Ugboko et al (45) | retrospective | 128 | total | # | 21–30 (38) |